Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Trial for Minimally Invasive Neurosurgery With AI-assisted Robotic Guidance for Moderate Basal Ganglia Hemorrhage (RAINBOW-MBH)
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Summary
A nationwide, prospective, multicenter randomized controlled clinical trial to evaluate the therapeutic effects of the fiber tract-based artificial intelligence (AI) Robot Guiding System on the perioperative and long-term recovery of patients with moderate-volume basal ganglion hemorrhage.
Official title: A Multicenter, RAndomlzed, coNtrolled, umBrella Trial fOr Minimally Invasive Neurosurgery With Al-assisted Robotic Guidance for Moderate Basal Ganglia Hemorrhage (RAINBOW-MBH)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
330
Start Date
2025-09-30
Completion Date
2027-12-31
Last Updated
2026-01-08
Healthy Volunteers
No
Conditions
Interventions
Minimally invasive basal ganglion hematoma evacuation with Tract-based AI Robot Guiding System
Basal ganglion hemorrhage patients will be operated on hematoma puncture and aspiration with Tract-based AI Robot Guiding System
Patients will be managed with guideline-based medications
Patients will be managed with guideline-based medications without surgery
Locations (1)
the Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China